3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Other
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
13
Obesity
3
Triple Negative Breast Neoplasms
2
Weight Gain
1
Stage IV Breast Cancer AJCC v6 and v7
1
Prostatic Neoplasms
1
Patient Compliance
1
Overweight
1
Ovarian Neoplasms
1
Motor Activity
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Fatigue
1
Endometrial Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Interventions
Exercise
72
Walking
9
Surveys and Questionnaires
8
Exercise Therapy
6
Diet
6
Resistance Training
5
High-Intensity Interval Training
5
Control Groups
4
methyl hydroxyethyl cellulose
3
Motivational Interviewing
3
Methods
3
Counseling
3
lime
2
Wearable Electronic Devices
2
Self-Management
2
Nutrition Assessment
2
Educational Status
2
Drug Therapy
2
Diet, Mediterranean
2
Creatine
2
Cognitive Behavioral Therapy
2
Behavior Therapy
2
Architectural Accessibility
2
pertuzumab
1
Whey Proteins
1
Trastuzumab
1
Transcranial Direct Current Stimulation
1
Therapeutics
1
Telemedicine
1
Somatotypes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Motor Activity
×
Diet Therapy
×
Breast
×
Clear all
NCT02622711
2020-01-30
InForma
European Institute of Oncology
Phase NA
Completed
262 enrolled